Board of Management
The Sanger Institute's Board of Management (BoM) includes the Heads of the five Science Programmes, the Chief Operating Officer, the Director of Scientific Operations, the Head of Finance, the Head of HR and a representative from Wellcome. There are also two observers.
The Board of Management is responsible for advising and supporting the Director in his management responsibilities. Specifically it ensures that the Institute’s science is delivered according to its research plans through effective leadership, management and oversight. The BoM has delegated authority from the GRL Executive and its members are as below:
Mike Stratton - Director
Mike is Director of the Sanger Institute and Chair of the Board of Management. Mike's Profile
Martin Dougherty - Chief Operating Officer
Michael Dunn - Head of Genetics and Molecular Sciences, Wellcome
Michael Dunn is the Wellcome representative on the Sanger Institute's Board of Management.
Peter Campbell - Head of Cancer, Ageing and Somatic Mutation Programme
Sarah Teichmann - Head of Cellular Genetics
Matt Hurles - Head of Human Genetics Programme
Dominic Kwiatkowski - Head of Parasites and Microbes Programme
Mark Blaxter - Head of Tree of Life Programme
Mark Blaxter is leading the Sanger Institute's newest research programme: The Tree of Life. Tree of Life Programme
Cordelia Langford - Director of Scientific Operations
Maggie Payne - Chief Financial Officer
Maggie Payne is the Chief Financial Officer for the Sanger Institute, Connecting Science and the Wellcome Genome Campus.
Charlie Weatherhogg - Director of Human Resources
Charlie Weatherhogg is Director of Human Resources for the Sanger Institute, Connecting Science and the Wellcome Genome Campus.
Julia Wilson - Associate Director